Facet Life Sciences Evolves Leadership Structure to Strengthen Product Pathmaking Solutions & Deepen Partnership Value
To support continued growth, Facet Life Sciences, a product pathmaker for emerging biotechnology, pharmaceutical, and device developers, today announced executive team changes. Facet helps lean science teams navigate FDA approval and commercialization in complex, high-risk markets. This growth reflects a strengthened commitment to providing clarity, direction, and stability to accelerate our clients’ programs with confidence. Transitions will take effect between Q2 and Q3 2026.
Facet Life Sciences Publishes Second Edition of FDA and Intellectual Property Strategies for Medical Device Technologies
Facet Life Sciences, a regulatory affairs and product development strategy partner, is proud to announce the release of the second edition of FDA and Intellectual Property Strategies for Medical Device Technologies, an updated resource for medical device innovators featuring six Facet Life Sciences experts as contributing authors.
